jump to content jump to footer
Portrait of Professor Christina Messiou, Consultant Radiologist at The Royal Marsden NHS Foundation Trust

AI-Powered Whole-Body MRI for Multiple Myeloma: Interview with Prof. Christina Messiou

Multiple myeloma poses a unique challenge for radiologists: the disease often affects the bone marrow unevenly, and conventional biopsies can only capture a small snapshot. Whole-body MRI has emerged as a highly sensitive imaging technique – and combined with AI-driven automation, it's opening up entirely new possibilities for diagnosis and treatment monitoring.

In this interview, Professor Christina Messiou (The Royal Marsden NHS Foundation Trust, Institute of Cancer Research London) explains how integrating an AI algorithm into mint Lesion is transforming image interpretation, why automated metrics like skeletal segmentation, fat fraction and longitudinal charting matter clinically, and where precision medicine for myeloma is headed next.

Read the full interview now: AI in Whole-Body MRI for Multiple Myeloma.

Success Story mintLesion Clinical Routine MRI Bone Lesions AI

Related Resources

Integrated prostate cancer workflow connecting radiology, urology, and pathology through structured reporting, MRI-guided biopsy, longitudinal follow-up, and AI-supported analysis.
mint Lesion supports an end-to-end prostate cancer workflow by connecting radiology, urology, and pathology within a unified digital environment. The platform enables structured mpMRI reporting, MRI/ultrasound fusion biopsy workflows, FHIR-based interoperability, active surveillance, and AI-supported quantification of metastatic disease.
Be Central to the Insight: A Structured, Data-Driven Approach Across the Prostate Pathway
Digital Integration for Multidisciplinary Teams  In the complex journey of prostate cancer diagnostics, the data contributed by every department is…
Research poster presentation on standardized tumor response assessments using mint Lesion at the NCCN Annual Conference 2026
Presentation of a research poster by Memorial Sloan Kettering Cancer Center on the use of mint Lesion for structured tumor response assessments and clinical research workflows.
NCCN 2026: Memorial Sloan Kettering Cancer Center Presents Research on Structured Tumor Response Assessments with mint Lesion
Big congratulations to Steven Philemond and Alison Chiaramonte of Memorial Sloan Kettering Cancer Center for presenting their research poster “Use of…
Radiologist using mint Lesion for structured reporting and AI-supported workflows in lung cancer screening
How radiology practices can participate in lung cancer screening in Germany with mint Lesion through structured reporting, AI-supported workflows, and integrated collaboration with second-reading centers.
How Radiology Practices Can Participate in Germany’s Lung Cancer Screening Program with mint Lesion
New opportunities - but also economic uncertainty With the launch of lung cancer screening (LCS) in Germany, radiology practices are facing a new…